Biochemical and preclinical investigations suggest that AOD 9604 affects pathways involved in cellular energy regulation, including cyclic AMP signaling and downstream kinase activation
FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases
Haas break down two of the most talked-about nootropic bioregulators in the peptide world Pinealon and Dihexa and how they may support memory, neuroprotection, brain repair, and long-term cognitive performance
33 Oxidative stress is associated with the pathophysiology of cardiovascular diseases (CVDs), while antioxidants are involved in neutralizing ROS and protecting against oxidative stress
You are not a candidate for GLP-1 medications through our program if you are, or have a history of: Pancreatitis Thyroid cancer or multiple endocrine neoplasia syndrome (whether yourself or a first-degree relative) Currently pregnant or trying to become pregnant Crohns disease Gastroparesis, or have had a gastric bypass, gastric band, or gastric sleeve surgery Your safety is our top priority, and we carefully evaluate all patients to ensure the best treatment plan